Mumbai has emerged as a significant hub for pharmaceutical creation, with several firms specializing in the synthesis of Active Pharmaceutical Ingredients (APIs). Notably, a number of prominent businesses are focused on the production of Finasteride API (CAS No: 98319-26-7), meeting the global deman